Pharmaceutical Services

  • Forward integration of API companies.
  • Backward Integration of Finished Dosage Forms ( FP) companies.
  • Infrastructure Development ( Man, Machine ).
  • QbD Implementation .
  • Galenical/Lab scale Oral, Topical and Injectable Formulation Development.
  • Formulation Development of NCE
  • Bioavailabiltiy Enhancement of API through Formulation.
  • Formulation upgradation
  • Technology Transfer.
  • New Dosage Form
  • New Combinations.
  • s-New Drug Applications.